Applications of nano-baskets in drug development: High solubility and low toxicity

Drug and Chemical Toxicology

Volumn 36, Issue 1, 2013, Pages 119-132

  Mokhtari, Bahram ^a   Pourabdollah, Kobra ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Calixarene; Nanobasket; Solubility; Toxicity

Indexed keywords

4 SULFONATOCALIX[8]ARENE; 4 SULFONIC CALIX[N]ARENE DERIVATIVE; ANTIRETROVIRUS AGENT; ATROPINE; BETA CYCLODEXTRIN; CALIXARENE; CALIXARENE NANOBASKET; CARBAMAZEPINE; CELECOXIB; DIOXOURANIUM; DIOXOVANADIUM; FULLERENE DERIVATIVE; FUROSEMIDE; GAMMA CYCLODEXTRIN; MACROGOL; MANDELIC ACID DERIVATIVE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NANOBASKET; NANOPARTICLE; NICLOSAMIDE; NIFEDIPINE; PHENOTHIAZINE DERIVATIVE; PYRROLIZIDINE DERIVATIVE; RETRONECINE; RHENIUM COMPLEX; TETRACAINE; TOPOTECAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; URANIUM DERIVATIVE; VANADIUM DERIVATIVE;

BINDING AFFINITY; COVALENT BOND; DRUG ACTIVITY; DRUG BINDING; DRUG CONFORMATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MECHANISM; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; DRUG TOXICITY; HUMAN; MICELLE; NANOENCAPSULATION; NANOTECHNOLOGY; NONHUMAN; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; CALIXARENES; CARBAMAZEPINE; DRUG DISCOVERY; HUMANS; SOLUBILITY; STEREOISOMERISM; TETRACAINE; TOPOTECAN;

EID: 84865022984     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2011.653490     Document Type: Review

References (77)

1. Al-Jammaz, I., Amartey, J.K., Namor, A.F., Vora, M.M., Lambrecht, R.M. (2000). Novel separation of thallium-201 using p-tertbutylcalix[4]arene derivative. Radiochim Acta 88:179-184.
2. Anthony, W., Loris, C., Baggetto, G., Nicoleta, A., Mickael, L., Michaud, H., et al. (2010). Calixarene derivatives as anticancer agent. US Patent No. 20100056482.
3. Baeyer, A. (1872). Ueber die verbindungen der aldehyde mit den phenolen. (Aldehyde derivatives bearing phenols and aromatic hydrocarbons). Chem Ber 5:280-282.
4. Bayrakci, M., Ertul, S., Yilmaz, M. (2011). Transportation of poorly soluble drug molecules from the organic phase to the aqueous phase by using phosphorylated calixarenes. J Chem Eng Data 56:4473-4479.
5. Bezouska, K., Snajdrova, R., Krenek, K., Vancurova, M., Kadek, A., Adamek, D., et al. (2010). Carboxylated calixarenes bind strongly to CD69 and protect CD69+ killer cells from suicidal cell death induced by tumor cell surface ligands. Bioorg Med Chem 18:1434-1440.
6. van Bommel, K.J., Verboom, W., Hulst, R., Kooijman, H., Spek, A.L.,Reinhoudt, D.N. (2000). Calix[4]arene rhenium(V) complexes as potential radiopharmaceuticals. Inorg Chem 39:4099-4106.
7. Charnley, M., Fairfull-Smith, K., Williams, N.H., Haycock, J.W. (2006). Evaluation of anti-inflammatory calixarene-peptides for biomaterial modification. Eur Cells Mater 11(Suppl 3):26.
8. Colston, M.J., Hailes, H.C., Stavropoulos, E., Hervé, A.C., Hervé, G., Goodworth, K.J., et al. (2004). Antimycobacterial calixarenes enhance innate defense mechanisms in murine macrophages and induce control of Mycobacterium tuberculosis infection in mice. Infect Immun 72:6318-6323.
9. Consoli, G.M., Granata, G.,Geraci, C. (2011). Design, synthesis, and drug solubilising properties of the first folate-calix[4]arene conjugate. Org Biomol Chem 9:6491-6495.
10. Cornforth, J.W., Hart, P.D., Nicholls, G.A., Rees, R.J.,Stock, J.A. (1955). Antituberculous effects of certain surface-active polyoxyethylene ethers. Br J Pharmacol Chemother 10:73-88.
11. Cornut, D., Marrot, J., Wouters, J.,Jabin, I. (2011). Acid-base modulation of a versatile heteroditopic calix[6]arene based receptor. Org Biomol Chem 9:6373-6384.
12. Da Silva, D.L., Tavares, E.C., Conegero, L.S., Fatima, A., Pilli, R.A., Fernandes, S.A. (2010). NMR studies of inclusion complexation of the pyrrolizidine alkaloid retronecine and p-sulfonic acid calix[6]arene. J Incl Phenom Macrocycl Chem 69: 149-155.
13. Dibama, H.M., Clarot, I., Fontanay, S., Salem, A.B., Mourer, M., Finance, C., et al. (2009). Towards calixarene-based prodrugs: DRUG release and antibacterial behaviour of a water-soluble nalidixic acid/calix[4]arene ester adduct. Bioorg Med Chem Lett 19:2679-2682.
14. Ding, C., Qu, K., Li, Y., Hu, K., Liu, H., Ye, B., et al. (2007). Preparation and characterization of six calixarene bonded stationary phases for high performance liquid chromatography. J Chromatogr A 1170:73-81.
15. Durmaz, M., Bozkurt, S., Naziroglu, H.N., Yilmaz, M., Sirit, A. (2011). Chiral calix[4]arenes bearing aminonaphthol moieties as membrane carriers for amino acid methyl esters and mandelic acid. Tetrahedron Asymmetry 22:791-796.
16. Ersoz, M. (2007). Transport of mercury through liquid membranes containing calixarene carriers. Adv Colloid Interface Sci 134-135:96-104.
17. de Fátima, A., Fernandes, S.A., Sabino, A.A. (2009). Calixarenes as new platforms for drug design. Curr Drug Discov Technol 6:151-170.
18. Fernandes, S.A., Cabeca, L.F., Marsaioli, A.J., Paula, E. (2007). Investigation of tetracaine complexation with beta-cyclodextrins and p-sulphonic acid calix[6]arenes by nOe and PGSE NMR. J Incl Phenom Macrocycl Chem 57:395-401.
19. Galante, E., Geraci, C., Sciuto, S., Campo, V.L., Carvalho, I., Sesti-Costa, R., et al. (2011). Glycoclusters presenting lactose on calix[4]arene cores display trypanocidal activity. Tetrahedron 67:5902-5912.
20. Gharib, F., Hajmalek, M., Ahmadi Alamoti, R., Farajtabar, A. (2011). Complexation of dioxovanadium(V) and dioxouranium(VI) by p-sulphonato-calix[4] arene in aqueous solution. J Mol Liq 159:161-164.
21. Gordo, S., Martos, V., Vilaseca, M., Menéndez, M., de Mendoza, J.,Giralt, E. (2011). On the role of flexibility in protein-ligand interactions: The example of p53 tetramerization domain. Chem Asian J 6:1463-1469.
22. Gutsche, C.D., Muthukrishnan, R. (1978). Calixarenes. 1. Analysis of the product mixtures by the bas-catalyzed condensation of formaldehyde with para-substituted phenols. J Org Chem 43:4905-4936.
23. Harris, S.J. (1995). Calixarene-based compounds having antibacterial, antifungal, anticancer-HIV activity. WIPO Patent No. 019974.
24. Hart, P.D. (1968). Mycobacterium tuberculosis in macrophages: Effect of certain surfactants and other membrane-active compounds. Science 162:686-689.
25. Hashem, H.,Jira, T.H. (2005). The effect of the process variables on the HPLC separation of tricyclic neuroleptics on a calixarene-bonded stationary phase. Pharmazie 60:186-192.
26. Hashem, H., Trundelberg, C., Jira, T. (2010). Chromatographic application on calixarene bonded stationary phases: A stability indicating LC-method for determination of celecoxib in tablet formulation. Chromatographia 71:91-94.
27. Hwang, K.M., Qi, Y.M., Liu, S.Y., Lee, T.C., Choy, W., Chen, J. (1995). Antithrombotic treatment with calix(n)arene compounds. US Patent No. 5409959.
28. Inazumi, N., Sueishi, Y. (2010). Inclusion complexation of octaethylp-tert-butylcalix[8]arene octaacetate with methylene blue and control of its inclusion ability by alkali metal cations. J Incl Phenom Macrocycl Chem 68:93-98.
29. Inazumi, N., Yamamoto, S., Sueishi, Y. (2007). A characteristic effect of pressure on inclusion complexation of phenothiazine dyes with p-sulfonatocalix[6]arene in a room-temperature ionic liquid. J Incl Phenom Macrocycl Chem 59:33-39.
30. Kalchenko, V., Kukhar, V., Kosterin, S. (2007). Calixarenes for drug design. Sci Innov 12:816-823.
31. Krenek, K., Kuldová, M., Hulíková, K., Stibor, I., Lhoták, P., Dudic, M., et al. (2007). N-acetyl-D-glucosamine substituted calix[4]arenes as stimulators of NK cell-mediated antitumor immune response. Carbohydr Res 342:1781-1792.
32. Krishnan, A.M., Lohrmann, R. (1998). Calixarene conjugate diagnostic agents for computerized tomography and method for using same. US Patent No. 5846515.
33. Kunsagi-Mate, S., Vasapollo, G., Szabo, K., Bitter, I., Mele, G., Longo, L., et al. (2008). Effect of covalent functionalization of C60 fullerene on its encapsulation by water soluble calixarenes. J Incl Phenom Macrocycl Chem 60:71-78.
34. Latxague, L., Gaboriau, F., Chassande, O., Leger, J.M., Pires, V., Rouge, P., et al. (2011). Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. Part II. J Enzyme Inhib Med Chem 26:204-215.
35. Li, H., Findlay, I.A.,Sheppard, D.N. (2004). The relationship between cell proliferation, Cl- secretion, and renal cyst growth: A study using CFTR inhibitors. Kidney Int 66:1926-1938.
36. Li, H., Zhang, Y., Wang, X., Xiong, D., Bai, Y. (2007). Calixarene capped quantum dots as luminescent probes for Hg2+ ions. Mater Lett 61:1474-1477.
37. Macartney, D.H. (2011). Encapsulation of drug molecules by cucurbiturils: Effects on their chemical properties in aqueous solution. Israel J Chem 51:600-615.
38. Martin, A.D., Boulos, R.A., Hubble, L.J., Hartlieb, K.J.,Raston, C.L. (2011). Multifunctional water-soluble molecular capsules based on p-phosphonic acid calix[5]arene. Chem Commun (Camb) 47:7353-7355.
39. Menon, S.K., Modi, N.R., Mistry, B., Joshi, K. (2011). Improvement of some pharmaceutical properties of mycophenolate mofetil (MMF) by para sulphonatocalix[4]resorcinarene inclusion complex. J Incl Phenom Macrocycl Chem 70:121-128.
40. Mokhtari, B., Pourabdollah, K., Dalali, N. (2011). Analytical applications of calixarenes from 2005 up-to-date. J Incl Phenom Macrocycl Chem 69:1-55.
41. Mokhtari, B., Pourabdollah, K., Dalali, N. (2011). Applications of nano-baskets of calixarenes in chromatography. Chromatographia 73:829-847.
42. Mokhtari, B., Pourabdollah, K., Dalali, N. (2011). Molecule and ion recognition of nano-baskets of calixarenes since 2005. J Coord Chem 64:743-794.
43. Mokhtari, B., Pourabdollah, K., Dallali, N. (2011). A review of calixarene applications in nuclear industries. J Radioanal Nucl Chem 287:921-934.
44. Mokhtari, B., Pourabdollah, K. (2011). Binding abilities and extractive applications of nano-baskets of calixarene. Asian J Chem 23:4717-4734.
45. Mokhtari, B., Pourabdollah, K. (2011). Effect of crown size and upper moieties in nano-baskets of diacid calix[4]arene-1,2-crowns-3,4,5,6 on the extraction of s-block metals. J Coord Chem 64:3081-3091.
46. Mokhtari, B., Pourabdollah, K. (2011). Medical applications of nano-baskets. J Coord Chem 64:3189-3204.
47. Mokhtari, B., Pourabdollah, K. (2011). Solvent extraction of alkali metals by di-ionizable nano-baskets. J Coord Chem 64:4029-4053.
48. Mokhtari, B., Pourabdollah, K. (2011). Investigation of ionizable nanobaskets of calix[4]-1,2-crown-3 by differential pulse voltammetry. J Coord Chem 64:4079-4087.
49. Mokhtari, B., Pourabdollah, K. (2011). Structure optimization of di-ionizable calixarene nano-baskets for competitive solvent extraction of alkali and alkaline earth metals. Bull Korean Chem Soc 32:3855-3860.
50. Mokhtari, B., Pourabdollah, K. (2011). Effect of crown ring size and upper moiety on the extraction of s-block metals by ionizable calixcrown nano-baskets. Bull Korean Chem Soc 32:3979-3990.
51. Mokhtari, B., Pourabdollah, K. (2012). Binding and extraction of alkali and alkaline earth metals by ionizable calix[4]arene-1,2-crown-3 conformers. J Inclu Phenom Macrocycl Chem doi:10.1007/s10847-011-0052-1.
52. Mokhtari, B., Pourabdollah, K. (2012). Applications of calixarene nano-baskets in pharmacology. J Inclu Phenom Macrocycl Chem doi:10.1007s10847- 011-0062.
53. Mokhtari, B., Pourabdollah, K. (2012). Extraction of vanadyl porphyrins in crude oil by inclusion dispersive liquidYliquid microextraction and nano-baskets of calixarene. J Inclu Phenom Macrocycl Chem doi:10.1007/s10847- 011-0099.
54. Mourer, M., Psychogios, N., Laumond, G., Aubertin, A.M., Regnoufde-Vains, J.B. (2010). Synthesis and anti-HIV evaluation of watersoluble calixarene-based bithiazolyl podands. Bioorg Med Chem 18:36-45.
55. Mueller, A., Lalor, R., Cardaba, C.M.,Matthews, S.E. (2011). Stable and sensitive probes for lysosomes: Cell-penetrating fluorescent calix[4] arenes accumulate in acidic vesicles. Cytometry A 79A:126-136.
56. Neagu, M., Ion, R.M., Manda, G., Constantin, C., Radu, E., Cristu, Z. (2010). Antitumoral effect of calixarenes in experimental photodynamic therapy with K562 tumor cell line. Rom J Biochem 47:17-35.
57. Paclet, M.H., Rousseau, C.F., Yannick, C. Morel, F., Coleman, A.W. (2006). An absence of non-specific immune response towards para-sulphonato- calix[n]arenes. J Incl Phenom Macrocycl Chem 55:353-357.
58. Panchal, J.G., Patel, R.V., Menon, S.K. (2010). Preparation and physicochemical characterization of carbamazepine (CBMZ): Para-sulfonated calix[n]arene inclusion complexes. J Incl Phenom Macrocycl Chem 67:201-208.
59. Perret, F.,Coleman, A.W. (2011). Biochemistry of anionic calix[n] arenes. Chem Commun 47:7303-7319.
60. Pires, V.S., Gaboriau, F., Guillon, J., Nascimento, S., Dassonville, A., Lescoat, G., et al. (2006). Modulation of cell proliferation in rat liver cell cultures by new calix[4]arenes. J Enzyme Inhib Med Chem 21:261-270.
61. Rodik, R.V., Boyko, V.I.,Kalchenko, V.I. (2009). Calixarenes in biomedical researches. Curr Med Chem 16:1630-1655.
62. Rouge, P., Pires, V.S., Gaboriau, F., Dassonville-Klimpt, A., Guillon, J., Nascimento, S.D., et al. (2010). Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes. J Enzyme Inhib Med Chem 25:216-227.
63. Sayin, S., Ozcan, F., Yilmaz, M. (2011). Preparation and application of calix[4]arene derivatives bearing pyridinium units-grafted magnetite nanoparticles for removal of dichromate and arsenate anions. J Macromol Sci A 48:365-372.
64. Sayin, S., Yilmaz, E.,Yilmaz, M. (2011). Improvement of catalytic properties of Candida rugosa lipase by sol-gel encapsulation in the presence of magnetic calix[4]arene nanoparticles. Org Biomol Chem 9:4021-4024.
65. Sayin, S., Yilmaz, M., Tavasli, M. (2011). Syntheses of two diamine substituted 1, 3-distal calix[4]arene-based magnetite nanoparticles for extraction of dichromate, arsenate, and uranyl ions. Tetrahedron 67:3743-3753.
66. Sayin, S., Yilmaz, M. (2011). Preparation and uranyl ion extraction studies of calix[4]arene-based magnetite nanoparticles. Desalination 276:328-335.
67. Singh, A.K., Venglarik, C.J.,Bridges, R.J. (1995). Development of chloride channel modulators. Kidney Int 48:985-993.
68. Sueishi, Y., Asano, K. (2009). Effects of external pressure and solvent polarity on inclusion complexations of phenothiazine dyes and trans-4[-4-(dimethylamino)styryl]-1-methylpyridinium with water-soluble p-sulfonatocalix[8]arene in alcohol-water mixtures. J Incl Phenom Macrocycl Chem 63:37-42.
69. Tsou, L.K., Dutschman, G.E., Gullen, E.A., Telpoukhovskaia, M., Cheng, Y.C.,Hamilton, A.D. (2010). Discovery of a synthetic dual inhibitor of HIV and HCV infection based on a tetrabutoxycalix[4]arene scaffold. Bioorg Med Chem Lett 20:2137-2139.
70. Tu, C., Zhu, L., Li, P., Chen, Y., Su, Y., Yan, D., et al. (2011). Supramolecular polymeric micelles by the host-guest interaction of star-like calix[4]arene and chlorin e6 for photodynamic therapy. Chem Commun (Camb) 47:6063-6065.
71. Wang, G.S., Zhang, H.Y., Ding, F., Liu, Y. (2011). Preparation and characterization of inclusion complexes of topotecan with sulfonatocalixarene. J Incl Phenom Macrocycl Chem 69:85-89.
72. Yang, W., Otto, D.P., Liebenberg, W.,de Villiers, M.M. (2008). Effect of para-sulfonato-calix[n]arenes on the solubility, chemical stability, and bioavailability of a water insoluble drug nifedipine. Curr Drug Discov Technol 5:129-139.
73. Yang, W.,de Villiers, M.M. (2004). Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes. J Pharm Pharmacol 56:703-708.
74. Yang, W.,de Villiers, M.M. (2005). Effect of 4-sulphonato-calix[n]arenes and cyclodextrins on the solubilization of niclosamide, a poorly water soluble anthelmintic. AAPS J 7:E241E248.
75. Yordanov, A.T., Deal, K., Garmestani, K., Kobayashi, H., Herring, B., Waldmann, T.A., et al. (2000). Synthesis and biodistribution study of a new 211At-calix[4]arene complex. J Label Compd Radiopharm 43:1219-1225.
76. Zareh, M.M.,Malinowska, E. (2007). Phosphorated calix[6]arene derivatives as an ionophore for atropine-selective membrane electrodes. J AOAC Int 90:147-152.
77. Zinke, A., Ziegler, E. (1944). Zur kenntnis des härtungsprozesses von phenol-formaldehyd-harzen, X. Mitteilung. (Knowledge of the curing process of phenol-formaldehyde resins). Berichte der deutschen chemischen Gesellschaft 77:264-272.